Profiles

Keywords
Last Name
Institution
 Back to Details

Connection

Annabelle Volgman to Aged

This is a "connection" page, showing publications Annabelle Volgman has written about Aged.

 
Connection Strength
  
 
 
1.244
  
  1. Volgman AS, Nair G, Lyubarova R, Merchant FM, Mason P, Curtis AB, Wenger NK, Aggarwal NT, Kirkpatrick JN, Benjamin EJ. Management of Atrial Fibrillation in Patients 75 Years and Older: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022 01 18; 79(2):166-179.
    View in: PubMed
    Score: 0.083
  2. Abugroun A, Elawad A, Okoh AK, Abdel-Rahman ME, Ayinde H, Volgman AS. Impact of Atrial Fibrillation on Hospitalization Outcomes of Heart Failure in Patients = 60 Years with Implantable Cardioverter Defibrillator. Am J Cardiol. 2021 08 01; 152:94-98.
    View in: PubMed
    Score: 0.080
  3. Halloway S, Wilbur J, Braun LT, Schoeny ME, Volgman AS. The Feasibility of a Combined Lifestyle Physical Activity and Cognitive Training Intervention to Prevent Cognitive Impairment in Older Women With Cardiovascular Disease. J Phys Act Health. 2021 01 01; 18(1):70-75.
    View in: PubMed
    Score: 0.077
  4. Abugroun A, Taha A, Abdel-Rahman M, Volgman AS. Economic Impact of Atrial Fibrillation on Hospitalization Outcomes of Acute Heart Failure in the United States. Am J Cardiol. 2021 01 01; 138:124-127.
    View in: PubMed
    Score: 0.076
  5. Madan N, Gajo E, Sanghani RM, Volgman AS. Sex-Based Considerations in the Evaluation of Chest Pain and Management of Obstructive Coronary Artery Disease. Curr Atheroscler Rep. 2020 06 23; 22(8):39.
    View in: PubMed
    Score: 0.075
  6. Volgman AS, Lewis S, Wenger NK. Seniors on the Sidelines: A Call to Action. Circulation. 2020 06 09; 141(23):1836-1837.
    View in: PubMed
    Score: 0.074
  7. Volgman AS, Bairey Merz CN, Aggarwal NT, Bittner V, Bunch TJ, Gorelick PB, Maki P, Patel HN, Poppas A, Ruskin J, Russo AM, Waldstein SR, Wenger NK, Yaffe K, Pepine CJ. Sex Differences in Cardiovascular Disease and Cognitive Impairment: Another Health Disparity for Women? J Am Heart Assoc. 2019 10; 8(19):e013154.
    View in: PubMed
    Score: 0.071
  8. Halloway S, Wilbur J, Schoeny ME, Braun LT, Aggarwal NT, Miller AM, Crane MM, Volgman AS. Feasibility of a Lifestyle Physical Activity Intervention to Prevent Memory Loss in Older Women With Cardiovascular Disease: A Mixed-Methods Approach. Can J Nurs Res. 2020 Dec; 52(4):278-289.
    View in: PubMed
    Score: 0.070
  9. Lundberg GP, Mehta LS, Sanghani RM, Patel HN, Aggarwal NR, Aggarwal NT, Braun LT, Lewis SJ, Mieres JH, Wood MJ, Harrington RA, Volgman AS. Heart Centers for Women: Historical Perspective on Formation and Future Strategies to Reduce Cardiovascular Disease. Circulation. 2018 09 11; 138(11):1155-1165.
    View in: PubMed
    Score: 0.066
  10. Macario E, Schneider YT, Campbell SM, Volgman AS. Quality of Life Experiences among Women with Atrial Fibrillation: Findings from an Online Survey. Womens Health Issues. 2016 May-Jun; 26(3):288-97.
    View in: PubMed
    Score: 0.056
  11. Costello BT, Silverman ER, Doukky R, Braun LT, Aggarwal NT, Deng Y, Li Y, Lundberg G, Williams KA, Volgman AS. Lipoprotein(a) and Increased Cardiovascular Risk in Women. Clin Cardiol. 2016 Feb; 39(2):96-102.
    View in: PubMed
    Score: 0.055
  12. Attaya S, Bornstein T, Ronquillo N, Volgman R, Braun LT, Trohman R, Volgman A. Study of warfarin patients investigating attitudes toward therapy change (SWITCH Survey). Am J Ther. 2012 Nov; 19(6):432-5.
    View in: PubMed
    Score: 0.044
  13. Volgman AS, Manankil MF, Mookherjee D, Trohman RG. Women with atrial fibrillation: Greater risk, less attention. Gend Med. 2009 Sep; 6(3):419-32.
    View in: PubMed
    Score: 0.035
  14. Enriquez JR, Pratap P, Zbilut JP, Calvin JE, Volgman AS. Women tolerate drug therapy for coronary artery disease as well as men do, but are treated less frequently with aspirin, beta-blockers, or statins. Gend Med. 2008 Mar; 5(1):53-61.
    View in: PubMed
    Score: 0.032
  15. Moledina SM, Rashid M, Nolan J, Nakao K, Sun LY, Velagapudi P, Wilton SB, Volgman AS, Gale CP, Mamas MA. Addressing disparities of care in non-ST-segment elevation myocardial infarction patients without standard modifiable risk factors: insights from a nationwide cohort study. Eur J Prev Cardiol. 2022 05 25; 29(7):1084-1092.
    View in: PubMed
    Score: 0.021
  16. Ruge M, Gomez JMD, du Fay de Lavallaz J, Hlepas A, Rahman A, Patel P, Lavani P, Nair GG, Jahan N, Simmons JA, Rao AK, Williams KA, Volgman AS, Marinescu K, Suboc T. The prognostic value of cardiac troponin for 60 day mortality and major adverse events in COVID-19 patients. Cardiovasc Pathol. 2021 Nov-Dec; 55:107374.
    View in: PubMed
    Score: 0.020
  17. Halloway S, Schoeny ME, Barnes LL, Arvanitakis Z, Pressler SJ, Braun LT, Volgman AS, Gamboa C, Wilbur J. A study protocol for MindMoves: A lifestyle physical activity and cognitive training intervention to prevent cognitive impairment in older women with cardiovascular disease. Contemp Clin Trials. 2021 02; 101:106254.
    View in: PubMed
    Score: 0.019
  18. Hassan A, Abugroun A, Daoud H, Mahmoud S, Awadalla S, Volgman A, Alonso A. Impact of Gender Differences on Outcomes of Peripheral Artery Disease Intervention (from a Nationwide Sample). Am J Cardiol. 2021 02 15; 141:127-132.
    View in: PubMed
    Score: 0.019
  19. Okunrintemi V, Tibuakuu M, Virani SS, Sperling LS, Volgman AS, Gulati M, Cho L, Leucker TM, Blumenthal RS, Michos ED. Sex Differences in the Age of Diagnosis for Cardiovascular Disease and Its Risk Factors Among US Adults: Trends From 2008 to 2017, the Medical Expenditure Panel Survey. J Am Heart Assoc. 2020 12 15; 9(24):e018764.
    View in: PubMed
    Score: 0.019
  20. Kolkailah AA, Doukky R, Pelletier MP, Volgman AS, Kaneko T, Nabhan AF. Cochrane corner: transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis in people with low surgical risk. Heart. 2020 07; 106(14):1043-1045.
    View in: PubMed
    Score: 0.019
  21. Matetic A, Bharadwaj A, Mohamed MO, Chugh Y, Chugh S, Minissian M, Amin A, Van Spall H, Fischman DL, Savage M, Volgman AS, Mamas MA. Socioeconomic Status and Differences in the Management and Outcomes of 6.6 Million US Patients With Acute Myocardial Infarction. Am J Cardiol. 2020 08 15; 129:10-18.
    View in: PubMed
    Score: 0.019
  22. Mohamed MO, Greenspon A, Van Spall H, Volgman AS, Sharma PS, Alraies MC, Kwok CS, Martin GP, Zachariah D, Patwala A, Mamas MA. Sex differences in rates and causes of 30-day readmissions after cardiac electronic device implantations: insights from the Nationwide Readmissions Database. Int J Cardiol. 2020 03 01; 302:67-74.
    View in: PubMed
    Score: 0.018
  23. Martin GP, Kwok CS, Van Spall HGC, Volgman AS, Michos E, Parwani P, Alraies C, Thamman R, Kontopantelis E, Mamas M. Readmission and processes of care across weekend and weekday hospitalisation for acute myocardial infarction, heart failure or stroke: an observational study of the National Readmission Database. BMJ Open. 2019 08 22; 9(8):e029667.
    View in: PubMed
    Score: 0.018
  24. Mohamed MO, Volgman AS, Contractor T, Sharma PS, Kwok CS, Rashid M, Martin GP, Barker D, Patwala A, Mamas MA. Trends of Sex Differences in Outcomes of Cardiac Electronic Device Implantations in the United States. Can J Cardiol. 2020 01; 36(1):69-78.
    View in: PubMed
    Score: 0.018
  25. Mohamed MO, Sharma PS, Volgman AS, Bhardwaj R, Kwok CS, Rashid M, Barker D, Patwala A, Mamas MA. Prevalence, Outcomes, and Costs According to Patient Frailty Status for 2.9 Million Cardiac Electronic Device Implantations in the United States. Can J Cardiol. 2019 11; 35(11):1465-1474.
    View in: PubMed
    Score: 0.018
  26. Kwok CS, Walsh MN, Volgman A, Alasnag M, Martin GP, Barker D, Patwala A, Bagur R, Fischman DL, Mamas MA. Discharge against medical advice after hospitalisation for acute myocardial infarction. Heart. 2019 02; 105(4):315-321.
    View in: PubMed
    Score: 0.017
  27. Volgman AS, Carberry PA, Stambler B, Lewis WR, Dunn GH, Perry KT, Vanderlugt JT, Kowey PR. Conversion efficacy and safety of intravenous ibutilide compared with intravenous procainamide in patients with atrial flutter or fibrillation. J Am Coll Cardiol. 1998 May; 31(6):1414-9.
    View in: PubMed
    Score: 0.016
  28. Aggarwal NR, Patel HN, Mehta LS, Sanghani RM, Lundberg GP, Lewis SJ, Mendelson MA, Wood MJ, Volgman AS, Mieres JH. Sex Differences in Ischemic Heart Disease: Advances, Obstacles, and Next Steps. Circ Cardiovasc Qual Outcomes. 2018 02; 11(2):e004437.
    View in: PubMed
    Score: 0.016
  29. Cerwinske LA, Rasmussen HE, Lipson S, Volgman AS, Tangney CC. Evaluation of a dietary screener: the Mediterranean Eating Pattern for Americans tool. J Hum Nutr Diet. 2017 10; 30(5):596-603.
    View in: PubMed
    Score: 0.015
  30. Braun LT, Wilbur J, Buchholz SW, Schoeny ME, Miller AM, Fogg L, Volgman AS, McDevitt J. Cardiovascular Risk in Midlife African American Women Participating in a Lifestyle Physical Activity Program. J Cardiovasc Nurs. 2016 Jul-Aug; 31(4):304-12.
    View in: PubMed
    Score: 0.014
  31. Wilbur J, Miller AM, Fogg L, McDevitt J, Castro CM, Schoeny ME, Buchholz SW, Braun LT, Ingram DM, Volgman AS, Dancy BL. Randomized Clinical Trial of the Women's Lifestyle Physical Activity Program for African-American Women: 24- and 48-Week Outcomes. Am J Health Promot. 2016 05; 30(5):335-45.
    View in: PubMed
    Score: 0.014
  32. Ancheta IB, Battie CA, Volgman AS, Ancheta CV, Palaniappan L. Cardiovascular Disease Risk Score: Results from the Filipino-American Women Cardiovascular Study. J Racial Ethn Health Disparities. 2017 02; 4(1):25-34.
    View in: PubMed
    Score: 0.014
  33. Wilbur J, Buchholz SW, Ingram DM, Braun LT, Johnson TJ, Fogg L, Miller AM, Volgman AS, McDevitt J. Effectiveness, efficiency, duration, and costs of recruiting for an African American women's lifestyle physical activity program. Res Nurs Health. 2013 Oct; 36(5):487-99.
    View in: PubMed
    Score: 0.011
  34. Gomberg-Maitland M, Wenger NK, Feyzi J, Lengyel M, Volgman AS, Petersen P, Frison L, Halperin JL. Anticoagulation in women with non-valvular atrial fibrillation in the stroke prevention using an oral thrombin inhibitor (SPORTIF) trials. Eur Heart J. 2006 Aug; 27(16):1947-53.
    View in: PubMed
    Score: 0.007
  35. Raitt MH, Volgman AS, Zoble RG, Charbonneau L, Padder FA, O'Hara GE, Kerr D. Prediction of the recurrence of atrial fibrillation after cardioversion in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J. 2006 Feb; 151(2):390-6.
    View in: PubMed
    Score: 0.007
  36. Wyse DG, Slee A, Epstein AE, Gersh BJ, Rocco T, Vidaillet H, Volgman A, Weiss R, Shemanski L, Greene HL. Alternative endpoints for mortality in studies of patients with atrial fibrillation: the AFFIRM study experience. Heart Rhythm. 2004 Nov; 1(5):531-7.
    View in: PubMed
    Score: 0.006
  37. Buckingham TA, Radin MM, Volgman AS, Jhangiani A, Zbilut J. Does atrial fibrillation cause false-positive late potentials? Pacing Clin Electrophysiol. 1993 Dec; 16(12):2222-6.
    View in: PubMed
    Score: 0.003
  38. Susmano A, Volgman AS, Buckingham TA. Beneficial effects of dextro-amphetamine in the treatment of vasodepressor syncope. Pacing Clin Electrophysiol. 1993 Jun; 16(6):1235-9.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.